Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Invicta Diagnostic Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹85
Per ShareLot Size
1600 Shares
Minimum Investment
₹1,36,000
Issue Size
₹28.12 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
90.52%
Promoter Holding (Post-Issue)
66.7%
Issue Type
Book Building - SME
ISIN
INE0XJ501010
We are a diagnostic chain in Mumbai Metropolitan Region ("MMR") offering radiology and pathology solutions. We offer radiology and pathology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers under the brand name "PC Diagnostics" through our operational network, which consists of 7 diagnostic centres and 1 centralised laboratory across MMR in the state of Maharashtra either directly or through our subsidiaries.
Diagnostic services identify health conditions, ensuring diagnosis, treatment planning, and recovery. Catering to B2B (hospitals, clinics) and B2C (direct customers), these services are segmented into Pathology and Radiology. In India, the Radiology industry grew at a CAGR of 11.5% from 2020 to 2024 and is poised to grow from Rs. 407 billion in 2024 to Rs.868 billion by 2030 at a CAGR of 13.5%. In Maharashtra, it grew at a CAGR of 10.7% from 2020 to 2024 and is poised to grow from Rs. 15.04 billion in 2024 to Rs. 31.4 billion by 2030 at a CAGR of 13.1%.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of 33,08,800 equity shares of face value of Rs. 10/- each ("Equity Shares") for cash at a price of Rs. 85/- per equity share (including a premium of Rs. 75/- per equity share) ("Issue price") aggregating to Rs. 28.12 crores ("the Issue"). The issue will constitute 26.32 % of the post-issue paid up equity share capital of the company. The issue includes a reservation of 1,66,400 equity shares aggregating to Rs. 1.41 crores (constituting up to 1.32 % of the post issue paid-up equity share capital of the company) for subscription by market maker ("Market Maker Reservation Portion"). The issue less the market maker reservation portion is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.32 % and 25.00 % respectively, of the post-issue paid-up equity share capital of the company. Price Band: Rs. 85/- for equity share of face value of Rs. 10 each. The floor price is 8.50 times times the face value times of the face value of the equity shares. Bids can made for a minimum of 3,200 equity shares and in multiples of 1,600 equity shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Our Company was incorporated as Limited Liability Partnership under the name "Invicta Diagnostic LLP" under the provisions of the Limited Liability Partnership Act, 2008 vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre. Further, Invicta Diagnostic LLP was converted into a private limited company "Invicta Diagnostic Private Limited" pursuant to the provisions of Chapter XXI of the Companies Act, 2013 and a fresh Certificate of Incorporation dated December 01, 2023 was issued by Assistant Registrar of Companies, Central Registration Centre. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a resolution passed in the extraordinary general meeting of our Shareholders held on April 20, 2024 and the name of our Company was changed to "Invicta Diagnostic Limited" and a fresh certificate of incorporation dated July 02, 2024 was issued to our Company by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies, Central Processing Centre. The Corporate Identification Number of our Company is U86100MH2023PLC414723.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.